Zobrazeno 1 - 10
of 351
pro vyhledávání: '"Paul P. Carbone"'
Autor:
Paul P. Carbone, Thomas C. Havighurst, Eric R. Berg, David Puchalsky, Harry H. Sharata, Marcy Pomplun, Mary Hamielec, Nancy E. Dreckschmidt, Jeff Douglas, Jaye L. Viner, Theresa Lenaghan, Stephen Snow, Paul O. Larson, Karen Sielaff, Ajit K. Verma, KyungMann Kim, Howard H. Bailey
Preclinical studies have shown that the inhibition of ornithine decarboxylase (ODC) by α-difluoromethylornithine (DFMO) and resultant decreases in tissue concentrations of polyamines (putrescine and spermidine) prevents neoplastic developments in ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a85cf47cfe2314cd6ec79d264a7663a
https://doi.org/10.1158/1940-6207.c.6544632.v1
https://doi.org/10.1158/1940-6207.c.6544632.v1
Autor:
Paul P. Carbone, Thomas C. Havighurst, Eric R. Berg, David Puchalsky, Harry H. Sharata, Marcy Pomplun, Mary Hamielec, Nancy E. Dreckschmidt, Jeff Douglas, Jaye L. Viner, Theresa Lenaghan, Stephen Snow, Paul O. Larson, Karen Sielaff, Ajit K. Verma, KyungMann Kim, Howard H. Bailey
Perspective on this Article from A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of α-Difluoromethylornithine in Subjects with Previous History of Skin Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::065b692f59560fd99a405f506e993a39
https://doi.org/10.1158/1940-6207.22525221
https://doi.org/10.1158/1940-6207.22525221
Publikováno v:
Annals of the New York Academy of Sciences. 113:1081-1089
Autor:
Lodovico Balducci, Paul P. Carbone
Publikováno v:
Hospital Practice. 35:73-80
The body's ability to meet the stresses of cancer therapy declines in later life. Because the decline may vary and is only weakly linked to chronologic age, a thorough functional assessment should be undertaken in all elderly cancer patients. The res
Autor:
Wan Ki Hong, Paul P. Carbone
Publikováno v:
Hospital Practice. 34:101-106
Rather than attempting to treat cancer after it has developed-and often metastasized-a more promising alternative is to direct therapy at the precancerous cell. For cancers linked to smoking, especially breast cancer and cancers of the head and neck,
Publikováno v:
Investigational New Drugs. 16:315-318
Seventy-three eligible, chemotherapy-naive, ambulatory patients with advanced pancreatic carcinoma were allocated to one of two treatment regimens: 35 received PALA (1250 mg/m2 daily x 5 every 4 weeks) and 38 were given SAM (streptozotocin 400 mg/m2
Autor:
V. Craig Jordan, Paul P. Carbone
Publikováno v:
Hospital Practice. 33:59-78
Tamoxifen offers protection against the development or recurrence of breast cancer in a range of clinical circumstances, while simultaneously helping to prevent osteoporosis and perhaps coronary heart disease. The most serious side effects of this an
Autor:
Paul P. Carbone, James F. Cleary
Publikováno v:
Cancer. 80:1335-1347
Cancer is primarily a disease of the elderly and the palliation of both disease- and treatment-related symptoms is of importance in the practice of cancer medicine in all patients. Many older patients are treated within community hospitals, in which
Publikováno v:
Cancer. 78:1633-1637
BACKGROUND. Over the past 20 years, considerable progress has been made in the early detection and treatment of cancer. Despite these advances, cancer incidence and mortality rates among Native Americans have not kept pace. Cancer centers are in a un